BRPI0418420A - proteìnas, peptìdeos e sacarìdeos anticariogênicos - Google Patents
proteìnas, peptìdeos e sacarìdeos anticariogênicosInfo
- Publication number
- BRPI0418420A BRPI0418420A BRPI0418420-3A BRPI0418420A BRPI0418420A BR PI0418420 A BRPI0418420 A BR PI0418420A BR PI0418420 A BRPI0418420 A BR PI0418420A BR PI0418420 A BRPI0418420 A BR PI0418420A
- Authority
- BR
- Brazil
- Prior art keywords
- phosvitin
- conjugated
- proteins
- casein phosphopeptide
- partially
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 150000001720 carbohydrates Chemical class 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000000170 anti-cariogenic effect Effects 0.000 title 1
- 102100027992 Casein kinase II subunit beta Human genes 0.000 abstract 5
- 101710158100 Casein kinase II subunit beta Proteins 0.000 abstract 5
- 108010001441 Phosphopeptides Proteins 0.000 abstract 3
- 239000005018 casein Substances 0.000 abstract 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 3
- 235000021240 caseins Nutrition 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920001661 Chitosan Polymers 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Polyamides (AREA)
Abstract
PROTEìNAS, PEPTìDEOS E SACARìDEOS ANTICARIOGêNICOS. A presente invenção refere-se às novas proteínas, peptídeos e sacarídeos que possuem capacidade anticariogênica e que são caracterizados pela presença de um ou mais componentes que possuel a capacidade de formar um complexo com íons cálcio: tais como epsilon-polilisina que é conjugada com um ou mais grupos bisfosfonila, biscarboxila ou 3-hidroxiflalato ou conjugados com fosfopeptídeo de caseína, fosvitina ou com fosvitina parcialmente hidrolisada; tais como, quitosano parcialmente hidrolisado que é conjugado com um ou mais grupos bisfosfonila, fosfopeptídeo de caseína ou com fosvitina ou fosvitina parcialmente hidrolisada; tais como proteínas bisfosfoniladas e biscarboxiladas com pelo menos 40% dos aminoácidos consistindo em lisina e um peso molecular acima de 2 KD (2.000 Dálton) e tal como fosfopeptídeo de caseína polimerizado e fosvitina parcialmente hidrolisada. Polímeros especialmente básicos que são conjugados com grupos bisfosfonila, tais como, epsilon-polilisina bifosfonilada são protetores fortes devido a presença simultânea em uma molécula de complexação de cálcio e componentes tampão de ácido forte. Além disso, as polilisinas, tais como epsilon-polilisina demonstraram atividade antibacteriana contra uma grande variedade de bactérias de cavidade oral incluindo bactérias que produzem ácido. Isso indica sua relevância para proteção dos dentes especificamente para o controle da flora bacteriana na cavidade oral em geral. Os produtos podem ser usados em formulações para proteger os dentes e para tratar a cavidade oral: pastas de dentes, géis, colutórios, saliva artificial, para pacientes e consumidores saudáveis. Eles possuem um perfil toxicológico atraente em comparação ao fluoreto e podem ser usados em sistemas alimentícios; eles auxiliam também na ação do fluoreto. O uso em combinação com o fluoreto provê proteção excelente e melhorada em dosagem de fluoreto mínima. A invenção engloba estruturas competentes de proteínas, peptídeo e sacarídeo, com base em experimentos in vitro e in vivo, bem como procedimentos de produção e condições de aplicação.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE2004/0028A BE1015863A6 (nl) | 2004-01-19 | 2004-01-19 | Anticariogene proteinen & peptiden & sacchariden. |
| PCT/EP2004/013549 WO2005068645A2 (en) | 2004-01-19 | 2004-11-29 | Anticariogenic proteins & peptides & saccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0418420A true BRPI0418420A (pt) | 2007-05-15 |
Family
ID=34754164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0418420-3A BRPI0418420A (pt) | 2004-01-19 | 2004-11-29 | proteìnas, peptìdeos e sacarìdeos anticariogênicos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080226565A1 (pt) |
| EP (1) | EP1709069B1 (pt) |
| JP (1) | JP2007523891A (pt) |
| CN (1) | CN1922203A (pt) |
| AT (1) | ATE419828T1 (pt) |
| BE (1) | BE1015863A6 (pt) |
| BR (1) | BRPI0418420A (pt) |
| CA (1) | CA2553613A1 (pt) |
| DE (1) | DE602004018985D1 (pt) |
| DK (1) | DK1709069T3 (pt) |
| ES (1) | ES2320001T3 (pt) |
| RU (1) | RU2006129942A (pt) |
| WO (1) | WO2005068645A2 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0702021D0 (en) * | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| JP2009143874A (ja) * | 2007-12-17 | 2009-07-02 | Chisso Corp | オーラルケア製品 |
| JP2010160863A (ja) * | 2009-01-09 | 2010-07-22 | Hitachi Ltd | 光ディスク装置及び多層式ディスク |
| CN101838467B (zh) * | 2010-05-21 | 2013-05-29 | 南京农业大学 | 一种新型壳聚糖纳米颗粒及其制备方法 |
| DE102011077067A1 (de) * | 2011-06-07 | 2012-12-13 | Beiersdorf Ag | Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem odermehreren aromatischen Aldehyden |
| SG11201402057VA (en) | 2011-12-15 | 2014-06-27 | Colgate Palmolive Co | Oral care compositions |
| JP6112427B2 (ja) | 2012-03-13 | 2017-04-12 | 国立大学法人 岡山大学 | リジンオリゴマー誘導体及びそれからなる軟骨組織マーカー |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| CN103932914B (zh) * | 2013-09-03 | 2016-06-08 | 浙江康德药业集团股份有限公司 | 壳聚糖漱口液及其制备方法 |
| KR101664444B1 (ko) * | 2013-12-13 | 2016-10-12 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | 생분해성 의료용 접착제 또는 실란트 조성물 |
| GB201409451D0 (en) | 2014-05-28 | 2014-07-09 | Ipabc Ltd | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms |
| CN104248775B (zh) * | 2014-09-22 | 2015-11-25 | 片仔癀（上海）生物科技研发有限公司 | 一种羟基磷灰石-壳聚糖复合凝胶及其制备工艺与用途 |
| CN106446599A (zh) * | 2015-08-11 | 2017-02-22 | 中国科学院青岛生物能源与过程研究所 | 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法 |
| CN105767419A (zh) * | 2016-04-06 | 2016-07-20 | 俞祖勋 | 一种防龋齿糖果的制造方法 |
| CN110325172A (zh) * | 2017-03-16 | 2019-10-11 | 江崎格力高株式会社 | 能够促进牙齿的再矿化的口腔用组合物 |
| CN107233228A (zh) * | 2017-07-20 | 2017-10-10 | 杭州坦珮信息技术有限公司 | 一种防口臭和龋齿牙膏的制造方法 |
| JP7198453B2 (ja) * | 2019-01-30 | 2023-01-04 | 国立研究開発法人産業技術総合研究所 | リグニンスルホン酸とε－ポリリジンを成分とするイオン複合材料 |
| CA3185123A1 (en) * | 2020-07-07 | 2022-01-13 | Bet Bioscience Extraction Technologies Inc. | Phosvitin compositions and methods of making and using |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
| JP3114359B2 (ja) * | 1992-05-14 | 2000-12-04 | チッソ株式会社 | 抗う蝕および抗歯周病剤 |
| US5587147A (en) * | 1994-06-30 | 1996-12-24 | Church & Dwight Co., Inc. | Aqueous zinc-polyamide complex solution |
| AUPR517701A0 (en) * | 2001-05-21 | 2001-06-14 | University Of Melbourne, The | Dental restorative materials |
| WO2002103004A1 (en) * | 2001-06-15 | 2002-12-27 | The Children's Hospital Of Philadelphia | Surface modification for improving biocompatibility |
| JP3862013B2 (ja) * | 2002-09-13 | 2006-12-27 | ライオン株式会社 | 口腔用組成物 |
-
2004
- 2004-01-19 BE BE2004/0028A patent/BE1015863A6/nl not_active IP Right Cessation
- 2004-11-29 CN CNA2004800420765A patent/CN1922203A/zh active Pending
- 2004-11-29 US US10/586,563 patent/US20080226565A1/en not_active Abandoned
- 2004-11-29 DE DE602004018985T patent/DE602004018985D1/de not_active Expired - Fee Related
- 2004-11-29 BR BRPI0418420-3A patent/BRPI0418420A/pt not_active IP Right Cessation
- 2004-11-29 WO PCT/EP2004/013549 patent/WO2005068645A2/en not_active Ceased
- 2004-11-29 ES ES04803351T patent/ES2320001T3/es not_active Expired - Lifetime
- 2004-11-29 DK DK04803351T patent/DK1709069T3/da active
- 2004-11-29 JP JP2006548133A patent/JP2007523891A/ja not_active Withdrawn
- 2004-11-29 AT AT04803351T patent/ATE419828T1/de not_active IP Right Cessation
- 2004-11-29 RU RU2006129942/15A patent/RU2006129942A/ru unknown
- 2004-11-29 EP EP04803351A patent/EP1709069B1/en not_active Expired - Lifetime
- 2004-11-29 CA CA002553613A patent/CA2553613A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005068645A3 (en) | 2005-11-10 |
| JP2007523891A (ja) | 2007-08-23 |
| CA2553613A1 (en) | 2005-07-28 |
| DK1709069T3 (da) | 2009-05-11 |
| ES2320001T3 (es) | 2009-05-18 |
| WO2005068645B1 (en) | 2005-12-08 |
| ATE419828T1 (de) | 2009-01-15 |
| WO2005068645A2 (en) | 2005-07-28 |
| RU2006129942A (ru) | 2008-02-27 |
| EP1709069A2 (en) | 2006-10-11 |
| EP1709069B1 (en) | 2009-01-07 |
| BE1015863A6 (nl) | 2005-10-04 |
| DE602004018985D1 (de) | 2009-02-26 |
| CN1922203A (zh) | 2007-02-28 |
| US20080226565A1 (en) | 2008-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0418420A (pt) | proteìnas, peptìdeos e sacarìdeos anticariogênicos | |
| WO2003020756A3 (en) | Hybrid and tandem expression of neisserial proteins | |
| WO2008118017A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| UA106869C2 (uk) | Поліпептид ace2 | |
| DK1337157T3 (da) | Proteinhydrolysater | |
| BRPI0809821A2 (pt) | "composição de proteína hidrolisada, processo para a preparação de uma composição de proteína hidrolisada e produto alimentício" | |
| WO2007146269A3 (en) | Peptide fragments for inducing synthesis of extracellular matrix proteins | |
| IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
| DK1109831T3 (da) | Cytotoksiske peptider modificeret ved store eller lipofile dele | |
| NO20091441L (no) | Rekonstituerte surfaktanter med forbedrede egenskaper | |
| WO2003037932A3 (en) | Human coagulation factor vii polypeptides | |
| BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
| HRP20150523T1 (hr) | Kombinacija za lijeäśenje mukozitisa izazvanog zraäśenjem ili kemoterapijom | |
| SE0002202D0 (sv) | New peptides | |
| ATE430165T1 (de) | Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten | |
| ATE211391T1 (de) | Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
| ATE364999T1 (de) | Modifizierte lupinproteine zur herstellung einer wasser-dispergierbaren produktform fettlöslicher stoffe | |
| BR0316493A (pt) | ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres | |
| ATE362756T1 (de) | Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen | |
| BRPI0511005A (pt) | peptìdeos oligoméricos e seu uso para o tratamento de infecções por hiv | |
| DE69209505D1 (de) | Lipoaminosauren,ihre herstellung und verwendung | |
| BR0307048A (pt) | Composição farmacêutica orodispersìvel de perindoprila | |
| MY179236A (en) | Skin collagen production-promoting agent | |
| JPWO2023190812A5 (pt) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |